Tilray‘s (NASDAQ: TLRY) medical marijuana products will soon be available in the U.K. The Canadian company announced Tuesday that it has reached an agreement with British company Grow Pharma, under which the latter will import Tilray’s green medicine into the country. The financial terms of the deal were not disclosed.
The company said it expects its goods to become available in the U.K. by March.
As with several other European countries, marijuana consumption and use in the U.K. is allowed only by people who have been expressly granted permission to do so. The authority in this case is the country’s National Health Service.